Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-03-Speech-4-443-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110203.25.4-443-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Efforts in the field of the research and development of new drugs and vaccines that are effective against diseases such as tuberculosis, which, with each passing year, continues to take millions of lives throughout the world, must be stimulated and positive results warmly welcomed. Once these results have been obtained, it is necessary to make available the new advancements in science and technology to those who need them, without any kind of exclusion.
Therefore, the sole criterion for access must be need. In the third world, the payment of foreign debt and interest for servicing debt to rich countries represents a major drain on resources, which therefore do not go to health and education budgets, which are reduced to almost insignificance. The so-called ‘structural adjustment programmes’, imposed from outside, also contribute to this.
Therefore, the fight against diseases, which, like tuberculosis, spread in poverty, includes combating these mechanisms that create and sustain dependence and poverty. In this context, it is regrettable that making the new tuberculosis vaccine available to less developed countries – which obviously we advocate – can be advocated in the name of strengthening the role and leadership of the EU in these countries, as is done in the question that gave rise to this motion for a resolution."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples